Skip to main content

Table 2 Crude blood pressure values and hypertension prevalence according to genotypes in MDC-CVA

From: The Renalase Asp37Glu polymorphism is not associated with hypertension and cardiovascular events in an urban-based prospective cohort: the Malmö Diet and cancer study

   RNLS   RNLS   RNLS   RNLS   RNLS 
  rs2576178 AA rs2576178 AG rs2576178 GG rs2576178 A-carriers rs2576178 G-carriers
  n = 3,035 n = 2,183 n = 448 n = 5,218 n = 2,631
SBP, mmHg 141.63±18.96 140.42±18.91 141.77±18.89 141.12±18.95 140.65±18.91
DBP, mmHg 87.01±9.49 86.75±9.39 87.38±9.28 86.89±9.45 87.01±9.49
Hypertension, % 63.8 62.8 63.4 63.4 62.9
Antihypertensive treatment, % 16.0 16.8 15.8 16.3 16.6
   RNLS   RNLS   RNLS   RNLS   RNLS 
  rs2296545 CC rs2296545 CG rs2296545 GG rs2296545 C-carriers rs2296545 G-carriers
  n = 1,663 n = 2,768 n = 1,177 n = 4431 n = 3,945
SBP, mmHg 141.33±18.79 141.08±18.82 141.58±19.53 141.17±18.81 141.23±19.04
DBP, mmHg 87.08±9.32 86.94±9.41 86.95±9.62 86.99±9.38 86.95±9.47
Hypertension, % 63.5 63.5 63.2 63.5 63.4
Antihypertensive treatment, % 17.4 15.9 15.9 16.5 15.9
  1. SBP, systolic blood pressure; DBP, Diastolic blood pressure.